The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: ehsl_novel_nam
1 - 25 of 3
| Title | Creator | Description | Identifier | ||
|---|---|---|---|---|---|
| 1 |
 |
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley, Jinglan Pei, Paris Sidiropoulos, Christine Birchwood, Jennie Best, John Stone, Sebastian Unizony | The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated ... | 20190319_nanos_sciplatform3_08-abstract |
| 2 |
 |
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley, Jinglan Pei, Paris Sidiropoulos, Christine Birchwood, Jennie Best, John Stone, Sebastian Unizony | The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated ... | 20190319_nanos_sciplatform3_08_slides |
| 3 |
 |
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley, Jinglan Pei, Paris Sidiropoulos, Christine Birchwood, Jennie Best, John Stone, Sebastian Unizony | The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated ... | 20190319_nanos_sciplatform3_08-video |
1 - 25 of 3